Global Biopharmaceuticals Market Research Report 2015-2025
- HEY3817375
- 92 Pages
- April 2020
- Healthcare
The global Biopharmaceuticals market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Biopharmaceuticals Picture
1.1.2 Specifications
Table Product Specifications of Biopharmaceuticals
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Biopharmaceuticals
Table Global Biopharmaceuticals Market by Type, 2011-2022 (USD Million)
1.2.1.1 Monoclonal Antibodies
Table Monoclonal Antibodies Overview
1.2.1.2 Interferon
Table Interferon Overview
1.2.1.3 Colony-Stimulating Factor
Table Colony-Stimulating Factor Overview
1.2.1.4 Erythropoietin
Table Erythropoietin Overview
1.2.1.5 Insulin
Table Insulin Overview
1.2.1.6 Vaccines
Table Vaccines Overview
1.2.1.7 Growth Hormones
Table Growth Hormones Overview
1.2.1.8 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Biopharmaceuticals
Table Global Biopharmaceuticals Market by Application, 2011-2022 (USD Million)
1.2.2.1 Tumor
Table Tumor Overview
1.2.2.2 Diabetes
Table Diabetes Overview
1.2.2.3 Cardiovascular
Table Cardiovascular Overview
1.2.2.4 Hemophilia
Table Hemophilia Overview
1.2.2.5 Others
Table Others Overview
1.2.3 by Regions
Table Global Biopharmaceuticals Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Biopharmaceuticals
2.2 Upstream
Table Cost of Biopharmaceuticals
Figure Manufacturing Process of Biopharmaceuticals
2.3 Market
2.3.1 SWOT
Figure SWOT of Biopharmaceuticals
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Biopharmaceuticals
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Biopharmaceuticals
3.4 Market Entry
Table Market Entry of Biopharmaceuticals
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Monoclonal Antibodies Market, 2013-2018
Figure Monoclonal Antibodies Market Size and Growth, 2015-2019 (USD Million)
Figure Monoclonal Antibodies Market Size and Growth, 2015-2019 (in Volume)
Table Monoclonal Antibodies CAGR by Revenue and Volume, 2015-2019
4.1.2 Interferon Market, 2013-2018
Figure Interferon Market Size and Growth, 2015-2019 (USD Million)
Figure Interferon Market Size and Growth, 2015-2019 (in Volume)
Table Interferon CAGR by Revenue and Volume, 2015-2019
4.1.3 Colony-Stimulating Factor Market, 2013-2018
Figure Colony-Stimulating Factor Market Size and Growth, 2015-2019 (USD Million)
Figure Colony-Stimulating Factor Market Size and Growth, 2015-2019 (in Volume)
Table Colony-Stimulating Factor CAGR by Revenue and Volume, 2015-2019
4.1.4 Erythropoietin Market, 2013-2018
Figure Erythropoietin Market Size and Growth, 2015-2019 (USD Million)
Figure Erythropoietin Market Size and Growth, 2015-2019 (in Volume)
Table Erythropoietin CAGR by Revenue and Volume, 2015-2019
4.1.5 Insulin Market, 2013-2018
Figure Insulin Market Size and Growth, 2015-2019 (USD Million)
Figure Insulin Market Size and Growth, 2015-2019 (in Volume)
Table Insulin CAGR by Revenue and Volume, 2015-2019
4.1.6 Vaccines Market, 2013-2018
Figure Vaccines Market Size and Growth, 2015-2019 (USD Million)
Figure Vaccines Market Size and Growth, 2015-2019 (in Volume)
Table Vaccines CAGR by Revenue and Volume, 2015-2019
4.1.7 Growth Hormones Market, 2013-2018
Figure Growth Hormones Market Size and Growth, 2015-2019 (USD Million)
Figure Growth Hormones Market Size and Growth, 2015-2019 (in Volume)
Table Growth Hormones CAGR by Revenue and Volume, 2015-2019
4.1.8 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Others Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 Monoclonal Antibodies Market Forecast, 2020-2025
Figure Monoclonal Antibodies Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Monoclonal Antibodies Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Monoclonal Antibodies CAGR by Revenue and Volume, 2012-2024
4.2.2 Interferon Market Forecast, 2020-2025
Figure Interferon Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Interferon Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Interferon CAGR by Revenue and Volume, 2012-2024
4.2.3 Colony-Stimulating Factor Market Forecast, 2020-2025
Figure Colony-Stimulating Factor Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Colony-Stimulating Factor Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Colony-Stimulating Factor CAGR by Revenue and Volume, 2012-2024
4.2.4 Erythropoietin Market Forecast, 2020-2025
Figure Erythropoietin Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Erythropoietin Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Erythropoietin CAGR by Revenue and Volume, 2012-2024
4.2.5 Insulin Market Forecast, 2020-2025
Figure Insulin Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Insulin Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Insulin CAGR by Revenue and Volume, 2012-2024
4.2.6 Vaccines Market Forecast, 2020-2025
Figure Vaccines Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Vaccines Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Vaccines CAGR by Revenue and Volume, 2012-2024
4.2.7 Growth Hormones Market Forecast, 2020-2025
Figure Growth Hormones Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Growth Hormones Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Growth Hormones CAGR by Revenue and Volume, 2012-2024
4.2.8 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Tumor Market, 2013-2018
Figure Tumor Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Tumor CAGR by Revenue and Volume, 2015-2019
5.1.2 Diabetes Market, 2013-2018
Figure Diabetes Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Diabetes CAGR by Revenue and Volume, 2015-2019
5.1.3 Cardiovascular Market, 2013-2018
Figure Cardiovascular Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Cardiovascular CAGR by Revenue and Volume, 2015-2019
5.1.4 Hemophilia Market, 2013-2018
Figure Hemophilia Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Hemophilia CAGR by Revenue and Volume, 2015-2019
5.1.5 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Tumor Market Forecast, 2020-2025
Figure Tumor Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Tumor Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Tumor CAGR by Revenue and Volume, 2020-2025
5.2.2 Diabetes Market Forecast, 2020-2025
Figure Diabetes Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Diabetes Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Diabetes CAGR by Revenue and Volume, 2020-2025
5.2.3 Cardiovascular Market Forecast, 2020-2025
Figure Cardiovascular Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Cardiovascular Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Cardiovascular CAGR by Revenue and Volume, 2020-2025
5.2.4 Hemophilia Market Forecast, 2020-2025
Figure Hemophilia Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Hemophilia Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Hemophilia CAGR by Revenue and Volume, 2020-2025
5.2.5 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Biopharmaceuticals Market by Vendors, 2015-2019 (in Volume)
Table Global Biopharmaceuticals Market Share by Vendors, 2015-2019 (USD Million)
Table Global Biopharmaceuticals Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Biopharmaceuticals Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Roche
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Amgen
Table Amgen Profile List
Table Microecological Modulator Operating Data of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 AbbVie
Table AbbVie Profile List
Table Microecological Modulator Operating Data of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Sanofi-Aventis
Table Sanofi-Aventis Profile List
Table Microecological Modulator Operating Data of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Johnson & Johnson
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Novo Nordisk
Table Novo Nordisk Profile List
Table Microecological Modulator Operating Data of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Eli Lilly
Table Eli Lilly Profile List
Table Microecological Modulator Operating Data of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Novartis
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Merck
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Biopharmaceuticals
Table Products Segment of Biopharmaceuticals
Table Global Biopharmaceuticals Market by Type, 2011-2022 (USD Million)
Table Monoclonal Antibodies Overview
Table Interferon Overview
Table Colony-Stimulating Factor Overview
Table Erythropoietin Overview
Table Insulin Overview
Table Vaccines Overview
Table Growth Hormones Overview
Table Others Overview
Table Application Segment of Biopharmaceuticals
Table Global Biopharmaceuticals Market by Application, 2011-2022 (USD Million)
Table Tumor Overview
Table Diabetes Overview
Table Cardiovascular Overview
Table Hemophilia Overview
Table Others Overview
Table Global Biopharmaceuticals Market by Region, 2011-2022 (USD Million)
Table Cost of Biopharmaceuticals
Table Market Dynamics
Table Policy of Biopharmaceuticals
Table GDP of Major Countries
Table Technology of Biopharmaceuticals
Table Market Entry of Biopharmaceuticals
Table Monoclonal Antibodies CAGR by Revenue and Volume, 2015-2019
Table Interferon CAGR by Revenue and Volume, 2015-2019
Table Colony-Stimulating Factor CAGR by Revenue and Volume, 2015-2019
Table Erythropoietin CAGR by Revenue and Volume, 2015-2019
Table Insulin CAGR by Revenue and Volume, 2015-2019
Table Vaccines CAGR by Revenue and Volume, 2015-2019
Table Growth Hormones CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table Monoclonal Antibodies CAGR by Revenue and Volume, 2012-2024
Table Interferon CAGR by Revenue and Volume, 2012-2024
Table Colony-Stimulating Factor CAGR by Revenue and Volume, 2012-2024
Table Erythropoietin CAGR by Revenue and Volume, 2012-2024
Table Insulin CAGR by Revenue and Volume, 2012-2024
Table Vaccines CAGR by Revenue and Volume, 2012-2024
Table Growth Hormones CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Tumor CAGR by Revenue and Volume, 2015-2019
Table Diabetes CAGR by Revenue and Volume, 2015-2019
Table Cardiovascular CAGR by Revenue and Volume, 2015-2019
Table Hemophilia CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table Tumor CAGR by Revenue and Volume, 2020-2025
Table Diabetes CAGR by Revenue and Volume, 2020-2025
Table Cardiovascular CAGR by Revenue and Volume, 2020-2025
Table Hemophilia CAGR by Revenue and Volume, 2020-2025
Table Others CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Biopharmaceuticals Market by Vendors, 2015-2019 (in Volume)
Table Global Biopharmaceuticals Market Share by Vendors, 2015-2019 (USD Million)
Table Global Biopharmaceuticals Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Profile List
Table Microecological Modulator Operating Data of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Profile List
Table Microecological Modulator Operating Data of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis Profile List
Table Microecological Modulator Operating Data of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Profile List
Table Microecological Modulator Operating Data of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Profile List
Table Microecological Modulator Operating Data of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
